Topics overview

Topics overview

LASA has data available on many different topics in various functional domains. To make it easier for those who would like to make use of LASA data, the topic table below provides an overview of the topics for which data are available in LASA, the corresponding data file number, and the measurement cycles (waves) in which the topic is included. When clicking on the topic name, you will be re-directed to a page with more detailed documentation on the specific topic. This table is a concatenation of all theme tables which can be shown by clicking on the menu-items behind “themes”.

Legend

UC: Under Construction

*: Telephone interview held with respondent or proxy

**: not yet documented

Note I: some of the data are not yet available (in red)

Note II: the table is also horizontally scrollable. So, if e.g. the last column does not show, it can be made visible by sliding the horizontal scroll bar at the bottom of the table forwards. In the desktop version you can also click on an empty space in the table and use the right and left keys on the key board to move the table backwards and forwards

Note III: investigations for the K-wave take place in 2021-2022. Results for this wave will be made available in the course of 2022 or later. Most questionnaire items used in wave K have been available already (see PDF-files “…quest_nl” in the various topics).

 

Topics table

LASA-WAVE BCDE2BFGH3BMBIJK 
Cohort 1
Cohort 2
Cohort 3
Migrant Cohort
THEME BIOMATERIAL
Blood collection and overview
(routine) measurements

Response blood sampling /
DNA Date blood sampling

850


851
850


851
-


-
-


-
850


851
-


-
850


851
-


-
850


851
-


-

-


-
-


-
-


-
Routine measurements
(Albumin and cholesterol)

860860--860-860-860----
Adiponectin, leptin and ghrelin------879------
Apolipoprotein E (ApoE)
- Phenotyping
- Genotyping

870
-

-
-

-
-

-
-

-
870

-
-

-
-

-
-

-
-

-
-

-
-

-
-

-
-
Cholesterol, triglycerides and
fructosamin

-867-----------
COLIA1 (Collagen type I α1 Sp1
polymorphism in LASA)

-871-----------
Cortisol (total plasma cortisol,
corticosteroid binding globuline,
salivary cortisol)
- Serum cortisol
- Salivary cortisol




-
-



864
-



-
-



-
880/
881/
882



-
-



-
-



-
-



-
-



-
-



-
-



-
-



-
-



-
-
Hair cortisol
(LASA ancillary study)

Genetic polymorphisms
(VDR, GR, etc)
- Vit D Receptors
- Haplotypes



-
-


872
873


-
-


-
-


-
-


-
-


-
-


-
-


-
-


-
-


-
-


-
-


-
-
GWAS data
-X--X-X-X----
Exome Chip
-X----X------
Homocysteine, vitamin B12, MMA
-866
-----------
Bone-related hormones and
bone turnover

-862
-----------
Inflammation factors
- Pro-inflammatory cytokine
Interleukin-6 (IL-6)
- Acute-phase proteins C-reactive
protein (CRP)
- A1-antichymotrypsin (ACT)
861861------861----
Serum Amyloid P component
(SAP)

-868
-----------
Serum 25-hydroxy-vitamin D
(25(OH)D) and parathyroid
hormone (PTH)

-862
--862-862-862----
Sex hormones
-863
-----------
Thyroid function
-865
-----------
Vitamin K status
----869--------
THEME CARE
Attitudes about care032

112

-
-

-

-
-

-

-
-

-

-
-

112

-
-

112

-
-

112

-
-

112

-
-

112

-
-

112

-
-

112

-
-

112

175
-

112

175
Filial responsibility
expectations IM
- scaled
-

-
-

-
132

332
132

332
-

-
-

-
-

-
-

-
-

-
-

-
-

-
132

332
-

-
Vignettes about help
- total scores
-
-
-
-
074
274
-
-
-

-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Providing careBCDE2BFGH3BMBIJK
Providing assistance with
personal/household care

----142142142142142142142142142
Family caregiving to older adults
(LASA ancillary study)
X
Use of careBCDE2BFGH3BMBIJK
Use of personal/household care

- tel. proxy*
- tel. respondent*
033

-
-
033

603
703
033

603
703
033

603
703
033

-
-
033

603
703
033

603
703
033

603
703
033

-
-
033

-
-
033

603
703
033

603
703
033

603
703
Care evaluation033033033033033033033033033033033033033
Use of nursing care

- tel. proxy*
- tel. respondent*
-

-
-
-

-
-
-

-
-
-

-
-
-

-
-
-

-
-
-

-
-
033

603
703
033

-
-
033

-
-
033

603
703
033

603
703
033

603
703
Use of transport/admin. care

- tel. proxy*
- tel. respondent*
-

-
-
-

-
-
-

-
-
-

-
-
-

-
-
-

-
-
-

-
-
033

603
703
-

-
-
-

-
-
033

603
703
033

603
703
033

603
703
Personal budget (PGB)-------033-----
Perceived control of care-------033033033033033033
Satisfaction with care033033033033033033033033033033033033033
Need for care-----033033033033033033033033
Aggr. variables care network-------233-----
Use of respite care by R
(for partner)
----------139139139
Perceived control in health care
and scale (LASA ancillary study)
       X   
Transitions in care
(LASA ancillary study)
**
Adaptations and facilitiesBCDE2BFGH3BMBIJK
Adaptations in the house
(see Theme SOCIAL)
Use of assistive devices or
assistence

(see Theme PHYSICAL)
Contact with servicesBCDE2BFGH3BMBIJK
Contact with health and social
services
044044044044044044044044044044044044044
Hospital admission

- tel. proxy*
- tel. respondent*
045

-
-
045

603
703
045

603
703
045

603
703
045

-
-
045

603
703
045

603
703
045

603
703
045

-
-
045

-
-
045

603
703
045

603
703
045

603
703
Outpatient contact with medical
specialists last 6 months
- specification of specialist
045

245
045

245
045

245
045

245
045

245
045

245
045

245
045

245
045

245
045

245
045

245
045

245
045

245
Health care in country of origin
---------068---
Needs assessmentBCDE2BFGH3BMBIJK
Needs assessment
(WVG/Wmo/AWBZ/Zvw/Wlz)IM


- tel. proxy*
- tel. respondent*

- tel. proxy*
- tel. respondent*
-
-
-

-
-

-
-
-
-
-

-
-

-
-
-
-
-

-
-

-
-
-
-
189

610
710

-
-
-
-
-

-
-

-
-
-
-
189

610
710

-
-
177
178
189

-
-

611
711
177
178
189

-
-

611
711
-
-
-

-
-

-
-
-
-
-

-
-

-
-
177
178
189

-
710

611
711
177
178
189

610
710

611
711
177
178
189

610
710

611
711
            
End of life care and preferencesBCDE2BFGH3BMBIJK
Advance Directives


- tel. respondent*
-
-

-
-
-

-
093
-

709
-
-

-
-
-

-
-
195

-
-
195

-
-
195

-
-
-

-
-
-

-
-
195

-
-
195

-
-
195

-
Feelings and wishes about
life and death
----------127127127
Decisions in eol situations------148------
General eol goals
(see also Subj. life exp.)
------094094094-094094094
Last wishes-----146----- --
Advance Care Planning (ACP)----------108-108
Opinions about euthanasia and
end-of-life (eol) pill
122122122122122122122122122-122122122
End-of-life care: interviews
with proxies
(LASA ancillary study)
   X  X     
THEME COGNITIVE
Intelligence and cognitionBCDE2BFGH3BMBIJK
Crystallized intelligence (GIT ©)
- total scores
-
-
037
237
-
-
-
-
-
-
037
237
-
-
-
-
-
-
-
-
037
237
-
-
-
-
Fluid intelligence (RAVEN)
- scaled

Evaluation RAVEN
022
222


024
022
222


-
022
222


-
022
222


-
022
222


-
022
222


-
022
222


-
-
-

-
-
-

-
-
-

-
-
-

-
-
-

-
-
-

-
Head trauma

- tel. proxy*
- tel. respondent*
-

-
-
-

-
-
035

602
702
035

602
702
-

-
-
035

602
702
035

602
702
035

602
702
-

-
-
-

-
-
035

602
702
035

602
702
035

602
702
Information processing speed
(Coding task)
155155155155155155155155155-155155155
Mini-Mental State Examination
(MMSE)
- MMSE scaled
- MMSE subtraction/spelling

- tel. respondent*
021

221
421


-
021

221
421


707
021

221
421


707
021

221
421


707
021

221
421


-
021

221
421


707
021

221
421


707
021

221
421


707
021

221
421


-
021

221
421


-
021

221
421


707
021

221
421


707
021

221
421

707
Informant Quest. of COgn.
DEcline (IQCODE)
- tel. proxy*
- tel. respondent*
-
-
607
707


607

-


607

-
-
-


607

-


607

-


607

-
-
-
-
-


607

-


607

-


607

-
Executive functioningBCDE2BFGH3BMBIJK
Verbal fluency-------165165165165165165
Executive functioning
(Digit span)
-------166020-166166166
MemoryBCDE2BFGH3BMBIJK
Everyday memory023----023-------
Episodic memory (15WT)
- constructed
156
356
156
356
156
356
156
356
156
356
156
356
156
356
156
356
156
356
-
-
156
356
156
356
156
356
Memory complaints

- tel. respondent*
021

-
021

-
021

707
021

707
021

-
021

707
021

707
021

707
021

-
021

-
021

707
021

707
021

707
Metamemory
- scaled
124
324
124
324
124
324
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Memory partner---139-139139139139-139139139
DementiaBCDE2BFGH3BMBIJK
Dementia algorithm-XXXXXXX--X
Dementia parents

- tel. respondent*
-

-
-

-
092

702
-

-
092

-
-

-
-

-
-

-
-

-
-

-
-

-
-

-
-

-
Dementia partner---139-139139139139-139139139
 
THEME DEMOGRAPHICS
General variablesBCDE2BFGH3BMBIJK
(Non-)response**
more detailed non-response**
z002

002
z002

002
z002

002
z002

002
z002

002
z002

002
z002

002
z002

002
z002

002
-

002
z002

002
z002

002
z002

002
Age at interview**z008z008z008z008z008z008z008z008z008mb008z008z008z008
Time of measurement**z008z008z008z008z008z008z008z008z008mb008z008z008z008
Sex**1z004---z004---z004mb004---
Education1z004---z004---z004mb004---
Nationality**1z004---z004---z004mb004---
Ethnicity**1z004---z004---z004mb004---
Weight factors5   
MortalityBCDE2BFGH3BMBIJK
Mortality dataz990z990z990z990z990z990z990z990z990-z990z990z990
Mortality and cause of death

- Specified
z991

z992
z991

z992
z991

z992
z991

z992
z991

z992
z991

z992
z991

z992
z991

z992
z991

z992
-

-
z991

z992
z991

z992
z991

z992
GeographyBCDE2BFGH3BMBIJK
Urbanization2z095z095z095z095z095z095z095z095z095mb095z095z095z095
History of domestic addresses**z052z052z052z052z052z052z052z052z052-z052z052z052
  
Living arrangementsBCDE2BFGH3BMBIJK
Household composition**IM011011011011011011011011011011011011011
Housing characteristicsIM
see Theme Social
Marital and partner status

- tel. proxy*
- tel. respondent*
z010

-
-
z010

601
701
z010

601
701
z010

601
701
z010

-
-
z010

601
701
z010

601
701
z010

601
701
z010

-
-
mb010

-
-
z010

601
701
z010

601
701
z010

601
701
  
Religion3BCDE2BFGH3BMBIJK
Church affiliation-z038z038z038z038---z038038---
Church attendance--z038z038z038z038z038z038z038038z038038038
  
Socio-economic
status
BCDE2BFGH3BMBIJK
Occupation4016016016016016016016016016016016016016
Income
- Income specification
017
217
017
-
017
-
017
-
017
-
017
-
017
-
017
-
017 -017
-
017
-
017
-
017
-
Income decline / evaluation019019019019019019019019019019019019019
Health insurance**018------------
  
THEME EMOTIONAL
ADHDBCDE2BFGH3BMBIJK
ADHD
(LASA ancillary study)
- constructed
-

-
-

-
-

-
-

-
-

-
-

-
179

379
-

-
-

-
-

-
-

-
-

-
-

-
  
AnxietyBCDE2BFGH3BMBIJK
Anxiety symptomsIM
- scaled
026
226
026
226
026
226
026
226
-
-
026
226
026
226
026
226
026
226
026
226
026
226
026
226
026
226
Anxiety diagnosesX-XXX-XX--XX
Posttraumatic stress (PTSD)
- scaled
-
-
-
-
091
291
091
291
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
DepressionBCDE2BFGH3BMBIJK
Depressive symptoms
- scaled

- tel. proxy*
- tel. respondent*
025
225


-
-
025
225


606
706
025
225


606
706
025
225


606
706
025
225


-
-
025
225


-
706
025
225


-
706
025
225


-
706
025
225


-
-
025
225


-
-
025
225


-
706
025
225


-
706
025
225


-
706
Depression diagnosesXXXXXXXXX-XX
Depressive symptoms and
food-related behaviour
(LASA ancillary study)
 
Mental health problems
and food-related behaviour
(LASA ancillary study)
 
  
Evaluation of lifeBCDE2BFGH3BMBIJK
Important aspects of life110110110110110110110110110-110110110
Satisfaction with life and
happiness
- 'happiness-line'
110

-
110

-
110

094
110

-
110

-
110

-
110

-
110

-
110

-
-

-
110

-
110

-
110

-
Valuation of life
- scaled
-
-
-
-
-
-
137
337
-
-
137
337
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Generativity-----------802802
  
Personality traitsBCDE2BFGH3BMBIJK
Self-esteem
- scaled
027
-
027
227
027
227
027
227
027
227
027
227
027
227
027
227
027
227
-
-
027
227
027
227
027
227
Mastery
- scaled
027
227
027
227
027
227
027
227
027
227
027
227
027
227
027
227
027
227
027
227
027
227
027
227
027
227
Perceived self-efficacy
- scaled
028
228
028
228
028
228
028
228
028
228
028
228
028
228
028
228
028
228
-
-
028
228
028
228
028
228
Neuroticism and soc. inadequacy
- scaled
123
323
123
323
123
323
123
323
123
323
-
-
-
-
-
-
123
323
-
-
-
-
-
-
-
-
Meta-emotion029--- 143-------
Humor
- scaled
111
311
-
-
111
311
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
General self-regulation (GSR)
- scaled
-
-
-
-
-
-
-
-
-
-
-
-
149
349
149
349
-
-
-
-
-
-
-
-
-
-
  
(In)dependenceBCDE2BFGH3BMBIJK
Investment in independence-----144144144--144144144
Singing and musicBCDE2BFGH3BMBIJK
Singing and making music-------103--103103-
Religiousness1BCDE2BFGH3BMBIJK
Gerotranscendence
(Cosmic transcendence)
- scaled
-

-
038

238
038

238
038

238
038

238
038

238
-

-
-

-
-

-
-

-
-

-
-

-
-

-
Orthodoxy (Main int.)
- scaled
Orthodoxy (Self-adm. quest.)
- scaled
-
-
-
-
038
238

-
-
038
-
-
-
038
-
138
338
038
-
-
-
038
-
-
-
038
-
-
-
038
-
-
-
038
-
-
-
-
-
-
-
038
-
-
-
038
-
-
-
038
-
-
-
Praying-038038038038038038038038-038038038
Salience of
religion
- scaled

- tel. proxy*
- tel. respondent*
110
-
-

-
-
110
038
238


608
708
110
038
238


-
-
110
038
238


-
-
110
038
238


-
-
110
-
-

-
-
110
-
-

-
-
110
-
-

-
-
110
-
-

-
-
-
-
-

-
-
110
-
-

-
-
110
-
-

-
-
110
-
-

-
-
Religious coping--------105105---
SexualityBCDE2BFGH3BMBIJK
Sexuality120--120120120--120----
Gender identity**-----------804804
SleepBCDE2BFGH3BMBIJK
Sleep quality
- scaled
117
317
117
317
117
317
117
317
117
317
117
317
117
317
117
317
117
317
-
-
117
317
117
317
117
317
Stress and stressorsBCDE2BFGH3BMBIJK
Negative life eventsIM-272272272-272272272--272272272
Perceived stress
- scaled
-
-
-
-
-
-
-
-
-
-
-
-
-
-
104
304
104
304
-
-
-
-
-
-
-
-
Subjective ageBCDE2BFGH3BMBIJK
Subjective life expectancy/
subj. age
--094094-094094094--094094094
Attitude toward ageing071-----------071
Age norms070070070-070070070070070-070070070
WorryingBCDE2BFGH3BMBIJK
Worrying
- scaled
-
-
-
-
-
-
136
336
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
THEME SOCIAL
AffiliationBCDE2BFGH3BMBIJK
Need for affiliation
- scaled
078
278
-
-
-
-
078
278
141
341
-
-
141
341
-
-
-
-
-
-
-
-
-
-
-
-
HousingBCDE2BFGH3BMBIJK
Housing characteristics





Adaptations in the house
014
015

-
-

014
014
015

601
701

014
014
015

601
701

014
014
015

601
701

014
014
015

-
-

014
014
015

601
701

014
014
015

601
701

014
014
015

601
701

014
014
015

-
-

014
014
015

-
-

-
014
015

601
701

014
014
015

601
701

014
014
015


601
701

014
Relocation


- tel. proxy*
- tel. respondent*
014
015

-
-
014
015

601
701
014
015

601
701
014
015

601
701
014
015

-
-
014
015

601
701
014
015

601
701
014
015

601
701
014
015

-
-
-
-

-
-
014
015

601
701
014
015

601
701
014
015

601
701
Neighborhood characteristics015
z095
015
z095
015
z095
015
z095
015
z095
015
z095
015
z095
015
z095
015
z095
-
z095
015
z095
015
z095
015
z095
Pets in household**012012012012012012012012012-012012012
Residence in 1944**013------------
Partner relationshipBCDE2BFGH3BMBIJK
Relationship quality---139-139139139139-139139139
Relationships between
generations
BCDE2BFGH3BMBIJK
Parental data**----140---140----
Children**-
-
048
-
-
-
048
248
048
248
048
248
-
-
-
-
048
248
048
248
048
-
-
-
-
-
Filial responsibility expectations IM
- scaled
-
-
-
-
132
332
132
332
-
-
-
-
-
-
-
-
-
-
-
-
-
-
132
332
-
-
Vignettes about help
- total scores
-
-
-
-
074
274
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Grandchildren**-----049-------
Social networkBCDE2BFGH3BMBIJK
Personal network
- network size
047
247
047
247
047
247
047
247
047
247
047
247
047
247
047
247
047
247
-
-
047
247
047
247
047
247
Contact network--------167167167--
LonelinessBCDE2BFGH3BMBIJK
Loneliness
-scaled

- tel. respondent*

Existential loneliness
073
273


-

-
073
273


-

-
073
273


-

-
073
273


-

-
073
273


-

-
073
273


-

-
073
273


-

-
073
273


712


-
073
273


-

-
073
273


-

-
073
273


712


-
073
273


712

173
073
273

712


-
Social participationBCDE2BFGH3BMBIJK
Social participation
070

125
070

125
070

125
070

125
070

125
070

125
070

125
070

-
070

-
070

-
070

-
070

-
070

-
Environmental influence**121121121----------
Social normsBCDE2BFGH3BMBIJK
Values and norms**122122122122122122122122122-122122122
Social desirability
- scaled
**
-
-
130
330
-
-
-
-
-
-
130
330
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Social identity
- scaled
**
-
-
-
-
131
331
131
331
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
 Donorship** - - - - - - - - - -128128-
Ties with country of origin**---------069---
THEME WORK
Work and Retirement
characteristics
 
Work and Retirement

- tel. respondent*

016

-
016

-
016

-
016

-
016

-
016

-
016

-
016

-
016

-
016

-
016

713
016

713
016

713
Physical and psychosocial
Population Job Exposure Matrix
(GPJEM)

016016016016016016016016016 016016016016
Work Perception--------106 106106106106
THEME PHYSICAL
Blood pressureBCDE2BFGH3BMBIJK
Blood pressure/pulse
- retests
151
-
151
-
151
-
151
-
151
151
151
-
151
151
151
151
151
151
151
-
151
151
151
151
151
151
Body compositionBCDE2BFGH3BMBIJK
Anthropometry

- Weight and height

- Calf measurement

- Ankle, Knee and Pulse width

161

161

171

-
161

161

-

185
161

161

171

-
161

161

171

-
161

161

171

-
161

161

171

-
161

161

171

-
161

161

171

-
161

161

171

-
161

161

-

-
161

161

161

-
161

161

161

-
161

161

161


-
Weight and height:
history and weight changeIM

- tel. respondent*

160


-
160


-
160


-
160


-
160


-
160


-
160


-
160


-
160


-
160


-
160


714

160


714
160


714
Bio-electrical impedance
(subsample)
**
172---------- --
Birth weight
---134134---134-- --
Perceived body shape
- scaled
**
-
-
-
-
-
-
-
-
-
-
145
345
145
345

-
-
145
345
145
-
-
-
-
-
-
-
DXA (LASA ancillary study)
- Hip / lumbar spine scan
- Whole body scan
-
-
o41
o42
o41
o42
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Chronic diseasesBCDE2BFGH3BMBIJK
Self-report of chronic diseasesIM
- nr. of diseases reported

- tel. proxy*
- tel. respondent*

- longitudinally cleaned

035
235


-
-

435
035
235


602
702

435
035
235


602
702


-
035
235


602
702


-
035
235


-
-

-
035
235


602
702


-
035
235


602
702


-
035
235


602
702


-
035
235


-
-

-
035
235


-
-

-
035
235


602
702


-
035
235


602
702


-
035
235

602
702

-
GP informationg01g01-g01g01UC-g01g01-
Aortic calcification
(lateral radiographs)

-zo22zo22----------
Diabetes mellitus
(algorithm)

zdc1zdc1zdc1zdc1zdc2zdc1
zdc2
zdc1
zdc2
zdc1
zdc2


zdc3
-zdc1
zdc2
zdc3
UCUC
Rheumatoid Arthritis
(algorithm)

-UC-----------
Osteoarthritis hip
and knee
(algorithm)

zoa1
zoa1zoa1 zoa1zoa2zoa1
zoa2
zoa1
zoa2
zoa1
zoa2


zoa3
-zoa1
zoa2
zoa3
UCUC
Metabolic syndrome
-ch02-----------
Allostatic Load (algorithm)
-X-----------
Cardiovascular diseases
(algorithm)

zh01zh01zh01----------
Parkinson: early P. related signs**
--------096096---
Decubitus
(bedsores)

116
159
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Hyperthyroidism**
-182 182
----------
Back pain-182
182
182
---------
Bedridden
- 182182
--182
182
182
182
----
FertilityBCDE2BFGH3BMBIJK
Fertility (women)
119 1811- - 181 - - - 181
181
- - -
FallingBCDE2BFGH3BMBIJK
Falls

- tel. proxy*
- tel. respondent*

- Falls last year



-
-

-


605
705

187


605
705

187


-
-

-


-
-

-


-
-

-


-
-

-


-
-

-


-
-

187


-
-

187


-
-

-


-
-

187


-
-

187
Falls: circumstances and
consequences

--187
--------187187
Falls: environmental
conditions (home)
**
-180
180
----------
Falls: fear of falling
(FES: Falls Efficacy Scale)

-183
183
----------
Falls: prevention of fall
accidents (LASA ancillary study)

--X----------
Falls: 3y prospective fall
calendar (LASA ancillary study)
-X-----------
Falls: 1y prospective fall
calendar (LASA ancillary study)

------X------
DizzinessIM
-187
187
-187
187
187
187
187
-187
187187
Adjustments and walking aids**
--187187187187187187187-- --
Foot problems
-185185185-185------
FracturesBCDE2BFGH3BMBIJK
Fractures
- total waves B-F
- per wave

- tel. proxy*
- tel. respondent*
zo13
-

-
-
zo13
186

605
705
zo13
186

605
705
zo13
186

605
705
zo13
186

-
-
zo13
186

605
705
186

605
705
186

605
705
186

-
-
186

-
-
186

605
705
186

605
705
186

605
705
Vertebral deformities
-zo22zo22----------
Quantitative ultrasound of bone
-o31----o31------
Frailty
BCDE2BFGH3BMBIJK
Various definitions (e.g., frailty
phenotype, frailty index)

XX  X  X  X  X   X  XXXXX
LifestyleBCDE2BFGH3BMBIJK
Alcohol useIM
- scaled
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
Diet and food consumption


Lifestyle study
(LASA ancillary study)


Nutrition and food-related
behaviour (LASA ancillary study)

with subtopics:
- Eating patterns
- Weight(loss) and appetite
- Mindful eating
- Meals and snack
- Interoceptive awareness
of hunger and satiety
- Alexithymia
- Binge eating
- Eating styles
- Problems food intake
- Use of amenities
- Food products for older adults
- Dietary recommendations
- Sustainable behaviour
- Change in sleep and appetite
118
-

-
118
184

-
118
184

-
-
-

-
-
-

-
-
-

X
-
-

-
118
-

-
-
-

-
-
-

-
118
-

-
118
-

-
118
-

-
MicMac study
(LASA ancillary study)

X
Oral health
-----X2----126126126
Physical activityIM
046
046
046
046 046 046 046 046 046 046 046 046 046
Daily Physical Activity**----------- 162-
Early life physical activity-246
-----------
Perceived physical activity (LIVAS)
- scaled
114
314
114
314
114
314
114
314
114
314
114
314
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Accelerometry
(LASA ancillary studies)
- subsample (St. 1)
- subsample (St. 2)
- subsample (St. 3)
- subsample (St. 4)



-
-
-
-


-
-
-
-


-
-
-
-


-
-
-
-


-
-
-
-


X2
-
-
-


-
X
-
-


-
-
X3
-


-
-
-
-


-
-
-
-


-
-
-
X
 

-
-
-
-


-
-
-
-
Sedentary behavior
- scaled
- scaled

-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
101
301
501
101
301
501
101
301
501
101
301
501
101
301
501
101
301
501
101
301
501
SmokingIM
154 154 154 154 154 154 154 154 154 154 154 154 154
Medication/
supplements
BCDE2BFGH3BMBIJK
Medication and
food supplement use4
- types of medication

152

352
152

352
152

352
152

352
152

352
152

352
152

352
152

352
152

352
152

352
152

352
152

352
152

352
Food supplement use4
- Vitamin D use included
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
174
374
174
374
174
374
PainBCDE2BFGH3BMBIJK
Subjective painIM
- scaled

115
315

115
315

115
315

115
315

115
315

115
315

115
315

115
315

115
315

115
315

115
315

 115
315

115
315

Dealing with pain**
---188
------- --
Pain drawing
---188
------- --
Perception: VisionBCDE2BFGH3BMBIJK
Vision (self-report)IM
- total scores

- tel. proxy*
- tel. respondent*

031
231


-
-
031
231


604
704
031
231


604
704
031
231


604
704
031
231


-
-
031
231


604
704
031
231


604
704
031
231


604
704
031
231


-
-
031
-

-
-
031
231


604
704
031
231


604
704
031
231

604
704
Visual acuity test
- Vision-related quality of life

-
-
-
-
-
-
191
192

-
-
191
192
191
192
191
192
191
-
-
-
-
-
-
-
-
-
Vision: contrast sensitivity
157157157157157157-------
Perception: HearingBCDE2BFGH3BMBIJK
Hearing (self-report)IM
- total scores

- tel. proxy*
- tel. respondent*

031
231


-
-
031
231


604
704
031
231


604
704
031
231


604
704
031
231


-
-
031
231


604
704
031
231


604
704
031
231


604
704
031
231


-
-
031
-

-
-
031
231


604
704
031
231


604
704
031
231

604
704
Hearing: Speech
in Noise Test (SNT)
Hearing: SNT questions
-

-
-

-
-

-
193

194
-

-
193

194
193

194
-

-
-

-
-

-
193

194
-

-
-

-
Perception: smellBCDE2BFGH3BMBIJK
Olfactory function
--------S00
S01
S02
S00
S01
S02
---
Physical functioningBCDE2BFGH3BMBIJK
Funct. limitations (ADL)IM
- constructed

- tel. proxy*
- tel. respondent*


Use of assistive
devices or assistance


Limitations in joint mobility

Funct. limitations partner (ADL)
030
230


-
-

030


-

-
030
230


603
703

030


183

030
230


603
703

030


183

-
030
230


603
703

030


183

139
030
230


-
-

030


-

-
030
230


603
703

030


-

139
030
230


603
703

030


-

139
030
230


603
703

030


-

139
030
230


-
-

030


-

139
030
230


-
-

030


-

-
030
230


603
703

030


-

139
030
230


603
703

030


-

139
030
230

603
703

030



-

139
Global Activity Limitations
- tel. respondent*
033
-
033
703
033
703
033
703
033
-
033
703
033
703
033
703
033
-
-
-
033
703
033
703
033
703
Physical performance
034034034034034034034034034034034034034
Pulmonary function test
- Peak Flow
- Spirometry
(post bronchodilator)

158

-
158

-
158

-
158

-
--

-
158

-
158

-
-

168
-

-
-

-
-

-
-

-
Grip strength
-161161161161161161161161161161161161
Quality of life
BCDE2BFGH3BMBIJK
EuroQol
- scaled

-
-
-
-
-
-
135
335
-
-
135
335
135
335
135
335
135
335
-
-
135
335
-
-
-
-
Qualeffo-41
- (non)response
- Qualeffo scores
- total scores

-
-
-
-
-
-
-
-
-
o80
o81
o82
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
SF-12 Health Survey
- scaled
- scaled (Am.)

-
-
-
-
-
-
133
333
533
133
333
533
-
-
-
133
333
533
133
333
533
133
333
533
133
333
533
-
-
-
133
333
533
133
333
533
133
333
533
WHO Quality of Life**
----------133
133133
Self-rated health
- GHPQ
- GHPQ: scaled

- tel. proxy*
- tel. respondent*

036
113
313


-
-
036
113
313


602
702
036
113
313


602
702
036
113
313


602
702
036
113
313


-
-
036
113
313


602
702
036
113
313


602
702
036
113
313


602
702
036
113
313


-
-
036
-
-

-
-
036
-
-

602
702
036
-
-

602
702
036
-
-

602
702
LASA-wave BCDE2BFGH3BMBIJK